PMI/Private Medical Insurance

Government health reforms still pose an "unacceptably high risk to the NHS" and should be scrapped, according to the British Medical Association (BMA).

Health insurers and brokers have broadly supported the Office of Fair Trading's (OFT) view that the private healthcare market is ‘not working well for customers'.

The Cancer Drugs Fund has led to a ‘devastating divide' in access to treatment between England and other home nations, according to a cancer charity.

The private healthcare market ‘may not be working well for consumers', the Office of Fair Trading (OFT) has said.

Unison has called for an immediate halt to the government's Health and Social Care Bill that will reform the NHS and highlighted fears that private patients may get priority.

The National Institute for Health and Clinical Excellence (NICE) has rejected another cancer drug for the NHS due to its cost.

The NHS exceeded all seven of its targets for cancer diagnosis and treatment during the last year, new data has revealed.

The NHS Future Forum is to conduct a second stage of its listening exercise following a request by the government to assess its revised proposals.

The NHS is in good financial health after producing a surplus of £1.5bn over the last financial year but it faces a stiff challenge over the coming years.

With private medical insurance a stretch for many firms, Lee Andre makes the case for introducing cash plans into the workplace.